Signaling Pathways - Vascular Disrupting Agents (VDA) - Sphingosine kinases (SphKs) - Xanthine oxidoreductases - LPA Receptors
清除全部
- B7515 1-Oleoyl lysophosphatidic acid sodium saltTarget: LPA ReceptorsSummary: 激活LPA受体
- B1591 Ki16198Target: LPA ReceptorsSummary: LPA拮抗剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2298 Plinabulin (NPI-2358)中文名: 普那布林Target: Vascular Disrupting Agents (VDA)Summary: 血管破坏剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8360 Allopurinol中文名: 别嘌醇Target: Xanthine oxidoreductasesSummary: 黄嘌呤氧化酶抑制剂
- A1987 Ki164254 CitationTarget: LPA ReceptorsSummary: LPA受体拮抗剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A3170 AM9662 CitationTarget: LPA ReceptorsSummary: LPA1拮抗剂
- A3167 AM-095 free baseTarget: LPA ReceptorsSummary: 有效的LPA1受体拮抗剂